- Product Details
Keywords
- Ivabradine hydrochloride
- Ivabradine HCl
- 3-[3-[[(8S)-3,4-Dimethoxy-8-bicyclo[4.2.0]octa-1,3,5-trienyl]methyl-methylamino]propyl]-7,8-dimethoxy-2,5-dihydro-1H-3-benzazepin-4-one hydrochloride
Quick Details
- ProName: Ivabradine hydrochloride
- CasNo: 148849-67-6
- Molecular Formula: C27H36N2O5.HCl
- Appearance: white
- Application: Pharmaceutical raw materials
- DeliveryTime: 3-5 days
- PackAge: Aluminum bag for sample, 25kg/drum, or...
- Port: Tianjin
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 98%
- LimitNum: 100 Gram
Superiority
product Name |
Product Name: IVABRADINE HCL Cas no.:148849-67-6 assay:98.5% High quality, low price, high purity |
---|---|
Synonyms | 4-amino-n-[4,6-dimethyl-2-pyrimidinyl]benzene-sulfonamide sodium salt; sulfadimidine sodium; sulfamethazine sodium salt; (n(sup1)-(4,6-dimethyl-2-pyrimidinyl)sulfanilamido)-sodiu; 4-amino-n-(4,6-dimethyl-2-pyrimidinyl)-benzenesulfonamidmonosodiumsalt; bovibol; n(sup1)-(4,6-dimethyl-2-pyrimidinyl)-; sulfanilamidmonosodiumsalt; salesodicodella2-p-aminobenzensulfonamido-4,6-dimetil-; pirimidina; sodiumsulfadimidine; sodiumsulfametazine; sodiumsulfamethazine; sodiumsulfamethiazine; sodiumsulfamezathine; sodiumsulphamezathine; sulfamethazinesodium; sulmet; vesadin; benzenesulfonamide, 4-amino-n-(4,6-dimethyl-2-; pyrimidinyl)-, monosodium salt; sulfadimidine sodium(sm2-na)(ndc:56631-0901); sodiumsulphamethazine; 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide; sodium [(4-aminophenyl)sulfonyl](4,6-dimethylpyrimidin-2-yl)azanide |
Molecular Formula | C12H13N4NaO2S |
Molecular Weight | 300.312 |
CAS Registry Number | 1981-58-4 |
EINECS | 217-840-0 |
Molecular Structure |
|
Boiling point | 526.2°C at 760 mmHg |
Flash point | 272.1°C |
Vapour Pressur | 3.64E-11mmHg at 25°C |
Hazard Symbols | Xn:Harmful; |
Risk Codes | R22:; |
Safety Description | S36:; |
Details
Ivabradine Hydrochloride, also known as S-16257, is the hydrochloride salt preparation of Ivabradine, a bradycardic agent. Studies have shown that Ivabradine inhibits T cell migration and causes a decrease of chemokine-induced PI-3 kinase activity. Exposure of rabbit sinoatrial node cells to Ivabradine has been reported to cause a blockade of the hyperpolarization-activated I(f) current without resulting in a shift of the voltage range of the activation curve.